Natera Director Sheena Jonathan Sells 3070 Shares at $149.96/Share.

Natera, Inc. has announced that Director Sheena Jonathan has sold 3,070 shares at $149.96 per share on July 16, 2025.

Natera, Inc. [NTRA] has announced that Director Sheena Jonathan sold 3,070 shares of the company's common stock on July 16, 2025, at an average price of $149.96 per share. This transaction, reported through a Form 4 filing with the U.S. Securities and Exchange Commission, is part of a Rule 10b5-1 trading plan adopted by Jonathan on December 11, 2024 [1].

The sale, which was effected in multiple transactions, resulted in Jonathan's beneficial ownership of 245,704 shares following the reported transaction. It is noted that the shares were held for the benefit of the beneficiaries of the trust and that Jonathan disclaims any beneficial ownership over these securities [1].

The announcement comes amidst ongoing legal challenges for Natera, Inc. In a recent decision, U.S. District Judge Edward M. Chen awarded more than $2.9 million in attorney fees to Guardant Health, a medical diagnostics company, due to alleged misrepresentations by Natera and its counsel, Quinn Emanuel Urquhart & Sullivan [2].

Natera has maintained that it disagrees with the jury's decision and is seeking to overturn it. The company has filed a motion for judgment as a matter of law or for a new trial. The legal developments may have implications for the company's financial performance and stock price, although the immediate impact on the stock remains to be seen.

References:
[1] https://www.streetinsider.com/SEC+Filings/Form+4+Natera%2C+Inc.+For%3A+Jul+16+Filed+by%3A+Sheena+Jonathan/25071589.html
[2] https://www.abajournal.com/news/article/special-master-to-decide-whether-quinn-emanuel-lawyers-must-share-in-3m-sanction